Up a level |
Tervonen, Tommi, Angelis, Aris ORCID: 0000-0002-0261-4634, Hockley, Kimberley, Pignatti, Francesco and Phillips, Lawrence D. (2019) Quantifying preference in drug benefit-risk decisions. Clinical Pharmacology and Therapeutics, 106 (5). pp. 955-959. ISSN 0009-9236
Micaleff, Alain, Callreus, Tornbjorn, Phillips, Lawrence D., Hughes, Diana, Hockley, Kimberley, Wang, Nan and Luciani, David (2013) IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab). . PROTECT Consortium, London.